Browse our anti-C-MYC (MYC) Antibodies

Full name:
anti-V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) Antibodies (MYC)
On www.antibodies-online.com are 713 V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies from 34 different suppliers available. Additionally we are shipping C-MYC Kits (55) and C-MYC Proteins (29) and many more products for this protein. A total of 821 C-MYC products are currently listed.
Synonyms:
AU016757, bHLHe39, C-MYC, CMyc, LOC100136746, mMyc, MRTL, MYC, Myc2, MYCC, Niard, Nird, RNCMYC, zc-myc
list all antibodies Gene Name GeneID UniProt
Anti-Rat MYC MYC 24577 P09416
MYC 17869 P01108
MYC 4609 P01106

Show all species

Show all synonyms

All available anti-C-MYC Antibodies

Go to our pre-filtered search.

Top referenced anti-C-MYC Antibodies

  1. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN358293 : Qi, Gregory, Li, Brousal, West, Hann: p19ARF directly and differentially controls the functions of c-Myc independently of p53. in Nature 2004 (PubMed)
    Show all 5 references for 358293

  2. Human Monoclonal C-MYC Primary Antibody for IF, IHC (p) - ABIN1105578 : Liao, Thakur, Wu, Biliran, Sarkar: Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. in Critical reviews in oncogenesis 2008 (PubMed)
    Show all 4 references for 1105578

  3. Human Polyclonal C-MYC Primary Antibody for IHC (p), WB - ABIN197156 : Baudino, Cleveland: The Max network gone mad. in Molecular and cellular biology 2001 (PubMed)
    Show all 4 references for 197156

  4. Human Polyclonal C-MYC Primary Antibody for WB - ABIN197158 : Blackwood, Eisenman: Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. in Science (New York, N.Y.) 1991 (PubMed)
    Show all 4 references for 197158

  5. Human Monoclonal C-MYC Primary Antibody for EIA, FACS - ABIN119684 : Spandidos, Pintzas, Kakkanas, Yiagnisis, Mahera, Patra, Agnantis: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. in Anticancer research 1988 (PubMed)
    Show all 2 references for 119684

  6. Human Monoclonal C-MYC Primary Antibody for FACS, IHC (fro) - ABIN119682 : Evan, Lewis, Ramsay, Bishop: Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. in Molecular and cellular biology 1986 (PubMed)
    Show all 2 references for 119682

  7. Human Polyclonal C-MYC Primary Antibody for IF (cc), IF (p) - ABIN1387773 : Gao, Zhao, Song, Yang: Expression pattern of embryonic stem cell markers in DFAT cells and ADSCs. in Molecular biology reports 2012 (PubMed)
    Show all 2 references for 1387773

  8. Human Polyclonal C-MYC Primary Antibody for WB - ABIN2668789 : Kohn, Yang, Du, Nagano, Van Schyndle, Herrmann, Heldman, Chen, Stuelten, Flanders, Wakefield: Biological responses to TGF-? in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. in Molecular cancer research : MCR 2012 (PubMed)

  9. Mammalian Monoclonal C-MYC Primary Antibody for IF, IP - ABIN1105582 : Watanabe, Honma, Furusawa, Sakurai, Sato: Preparation of enzymatically active human Myc-tagged-NCre recombinase exhibiting immunoreactivity with anti-Myc antibody. in Molecular reproduction and development 2006 (PubMed)

More Antibodies against C-MYC Interaction Partners

Mouse (Murine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. these results indicate that PIAS1 (show PIAS1 Antibodies) is a positive regulator of MYC.

  2. this study shows that that deletion of Sox2 (show SOX2 Antibodies) increases the frequency of IgH:c-Myc translocations

  3. findings highlight a MYC/ERRalpha (show ESRRA Antibodies) pathway that contributes to physiological and pathological bone loss by integrating the MYC/ERRalpha (show ESRRA Antibodies) axis to drive metabolic reprogramming during osteoclast differentiation

  4. KrasG12D-driven proliferation of pancreatic ductal epithelial cells (PDECs) depends on an EGFR (show EGFR Antibodies) signaling loop engaging the oncogenic transcription factor c-MYC.

  5. Data show that Emu-Myc mice lacking both p21 (show D4S234E Antibodies) and PUMA (show BBC3 Antibodies) developed lymphoma at a rate considerably longer latency than Emu-Myc;p53 (show TP53 Antibodies)(+/-)mice.

  6. CRY2 (show CRY2 Antibodies) and FBXL3 (show FBXL3 Antibodies) cooperatively degrade c-MYC preventing the development of cancer.

  7. Data, including data from studies in cells from knockout mice, suggest that Prmt1 (show PRMT1 Antibodies) activity was necessary for c-Myc binding to acetyltransferase p300 (show NOTCH1 Antibodies) in myeloid cells; Prmt1 (show PRMT1 Antibodies) inhibition decreases p300 (show NOTCH1 Antibodies) recruitment to c-Myc target promoters and increased Hdac1 (show HDAC1 Antibodies) recruitment. [Prmt1 (show PRMT1 Antibodies), protein arginine N-methyltransferase 1 (show PRMT1 Antibodies); c-Myc = Proto-Oncogene (show RAB1A Antibodies) Proteins c-myc; Hdac1 (show HDAC1 Antibodies) = histone deacetylase 1 (show HDAC1 Antibodies)]

  8. MYC-dependent attenuation of GCLC (show GCLC Antibodies) by miR (show MLXIP Antibodies)-18a contributes to GSH depletion in vivo, and low GSH corresponds with increased sensitivity to oxidative stress in tumors.

  9. MYC mediates cell cycle re-entry of Trp53 (show TP53 Antibodies)-altered hepatocytes via AURKA (show AURKA Antibodies) binding.

  10. Modification of the tumor microenvironment in KRAS or c-MYC-induced ovarian cancer-associated peritonitis has been described.

Zebrafish V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Apoptosis was also observed with myca expression; introduction of homozygous tp53 (show TP53 Antibodies)(-/-) mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression.

  2. MYC down-regulation induces mitochondrial apoptosis in T lymphoblasts.

Human V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. The results strongly suggest that the combination of MYCL plus MYOD1 (show MYOD1 Antibodies) may promote direct conversion of human fibroblasts into functional myoblasts that could potentially be used for regenerative therapy for muscle diseases and congenital muscle defects.

  2. EGFR (show EGFR Antibodies) amplification/EGFRvIII mutation can repress the expression of Pri-miR (show MLXIP Antibodies)-524 by histone modification. MiR (show MLXIP Antibodies)-524-3p and miR (show MLXIP Antibodies)-524-5p inhibited TGF/beta (show TGFB1 Antibodies), Notch (show NOTCH1 Antibodies) and the Hippo pathway by targeting Smad2 (show SMAD2 Antibodies), Hes1 and Tead1 (show TEAD1 Antibodies), respectively; these pathways repressed their common downstream transcription factor, C-myc.

  3. The data provided new insights into the functional interaction between the KRAS and MYC pathways across various cancer types

  4. these results indicate that PIAS1 (show PIAS1 Antibodies) is a positive regulator of MYC.

  5. MYC and BCL2 (show BCL2 Antibodies) genetic alterations were profiled using next-generation sequencing and high-resolution single nucleotide polymorphism array in 347 de novo diffuse large B-cell lymphoma cases.

  6. Activation of stromal MYC was critical for this reprogramming and for the sustained cellular responses elicited by LO, both in vitro and in vivo in an AKT1 (show AKT1 Antibodies)-dependent manner. Inhibition of LO internalization prevented activation of MYC and impaired the tumor-supporting properties of fibroblasts.

  7. High MYC expression is associated with skin neoplasms.

  8. this review discusses how MYC suppresses immune surveillance, and how oncogene (show RAB1A Antibodies)-targeted therapies may restore the immune response against tumors

  9. The clinicopathologic features of 187 large B-cell lymphomas with MYC fluorescence in situ hybridization were investigated. Patients with double/triple-hit lymphomas, but not single-hit lymphomas, had a significantly worse prognosis even among double/triple-hit lymphomas

  10. The CCND1 (show CCND1 Antibodies) genes were found very close to the IGH locus in naive B cells and further away after maturation. In contrast, the CMYC alleles became localized closer to an IGH locus at the stage of SHM (show CNTNAP1 Antibodies)/CSR (show MORF4 Antibodies).

Rabbit V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. report the isolation of complete coding regions of rabbit SOX2, KLF4, C-MYC and NANOG, which encode transcription factors that play crucial regulatory roles during early mammalian embryonic development

Cow (Bovine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Ouabain-induced proliferation might be attributed, at least in part, to decrease of intracellular free calcium and increase of c-myc mRNA expression, and that may be directly or indirectly involved in regulation of blood pressure.

C-MYC (MYC) Antigen Profile

Antigen Summary

The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene.

Alternative names and synonyms associated with C-MYC (MYC)

  • v-myc myelocytomatosis viral oncogene homolog (LOC100136746) antibody
  • myelocytomatosis oncogene (Myc) antibody
  • myelocytomatosis oncogene a (myca) antibody
  • v-myc avian myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) antibody
  • AU016757 antibody
  • bHLHe39 antibody
  • C-MYC antibody
  • CMyc antibody
  • LOC100136746 antibody
  • mMyc antibody
  • MRTL antibody
  • MYC antibody
  • Myc2 antibody
  • MYCC antibody
  • Niard antibody
  • Nird antibody
  • RNCMYC antibody
  • zc-myc antibody

Protein level used designations for MYC

v-myc myelocytomatosis viral oncogene homolog , Avian myelocytomatosis viral (v-myc) oncogene homolog , myc proto-oncogene protein , myelocytomatosis viral oncogene homolog , proto-oncogene c-Myc , transcription factor p64 , v-myc avian myelocytomatosis viral oncogene homolog , c-myc proto-oncogene , C-Myc1 , c-Myc-A , cellular myelocytomatosis oncogene , cmyca , transcriptional regulator Myc-A , avian myelocytomatosis viral oncogene homolog , class E basic helix-loop-helix protein 39 , myc-related translation/localization regulatory factor , avian myelocytomatosis viral (v-myc) oncogene homolog , c-Myc , Proto-oncogene c-Myc , Transcription factor p64 , Myc proto-oncogene protein

GENE ID SPECIES
100136746 Oncorhynchus mykiss
24577 Rattus norvegicus
17869 Mus musculus
30686 Danio rerio
4609 Homo sapiens
420332 Gallus gallus
100327265 Oryctolagus cuniculus
403924 Canis lupus familiaris
448810 Sus scrofa
511077 Bos taurus
100379628 Felis catus
443447 Ovis aries
694626 Macaca mulatta
464393 Pan troglodytes
100407754 Callithrix jacchus
100972175 Pan paniscus
Selected quality suppliers for anti-C-MYC (MYC) Antibodies
Did you look for something else?